Complication Rates of Bone Marrow Aspirate Concentrate Injections Versus Other Injectable Therapies .
Complication rates of bone marrow aspirate concentrate injections versus other injectable therapies for knee osteoarthritis: A systematic review and meta-analysis.
J Orthop . 2024 Oct 11:62:36-42.Six randomized controlled trials, including 860 patients with knee osteoarthritis, compared the complication rates of bone marrow aspirate concentrate (BMAC) injections versus other injectable therapies such as hyaluronic acid, steroids, platelet-rich plasma, and saline. The pooled overall complication rates were 41.91% for BMAC and 41.25% for comparison groups. No significant differences were observed in early or late complications. The findings suggest that BMAC injections are not associated with higher complication rates compared to other injectable therapies, supporting their safety in treating knee osteoarthritis.
Unlock the Full ACE Report
You have access to 4 more FREE articles this month.
Click below to unlock and view this ACE Reports
Unlock Now
Critical appraisals of the latest, high-impact randomized controlled trials and systematic reviews in orthopaedics
Access to OrthoEvidence podcast content, including collaborations with the Journal of Bone and Joint Surgery, interviews with internationally recognized surgeons, and roundtable discussions on orthopaedic news and topics
Subscription to The Pulse, a twice-weekly evidence-based newsletter designed to help you make better clinical decisions
Exclusive access to original content articles, including in-house systematic reviews, and articles on health research methods and hot orthopaedic topics
Or upgrade today and gain access to all OrthoEvidencecontent for as little as $1.99 per week.
Already have an account? Log in
0 of 4 monthly FREE articles unlocked
